DHR - Danaher Corp Stock Price, Fair Value and News

250.33USD-2.78 (-1.10%)Market Closed

Market Summary

USD250.33-2.78

Market Closed

-1.10%

DHR Stock Price

View Fullscreen

DHR RSI Chart

DHR Valuation

Market Cap

174.4B

Price/Earnings (Trailing)

39.62

Price/Sales (Trailing)

7.35

EV/EBITDA

33.57

Price/Free Cashflow

31.39

DHR Price/Sales (Trailing)

DHR Profitability

EBT Margin

19.03%

Return on Equity

8.24%

Return on Assets

5.28%

Free Cashflow Yield

3.19%

DHR Fundamentals

DHR Revenue

Revenue (TTM)

23.7B

Rev. Growth (Yr)

-2.57%

Rev. Growth (Qtr)

-9.51%

DHR Earnings

Earnings (TTM)

4.4B

Earnings Growth (Yr)

-23.86%

Earnings Growth (Qtr)

0.83%

Breaking Down DHR Revenue

Last 7 days

5.3%

Last 30 days

-0.7%

Last 90 days

10.7%

Trailing 12 Months

-0.5%

How does DHR drawdown profile look like?

DHR Financial Health

Current Ratio

1.85

Debt/Equity

0.31

Debt/Cashflow

0.42

DHR Investor Care

Buy Backs (1Y)

9.96%

Diluted EPS (TTM)

5.9

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	23.7B	0	0	0
2023	26.1B	25.4B	24.6B	23.9B
2022	24.5B	23.8B	23.0B	26.6B
2021	24.8B	26.7B	28.1B	24.8B
2020	18.0B	18.9B	20.4B	22.3B
2019	17.2B	17.4B	17.6B	17.9B
2018	18.1B	17.9B	17.5B	17.0B
2017	17.2B	17.4B	17.8B	18.3B
2016	15.2B	16.0B	16.6B	16.9B
2015	17.9B	16.5B	15.3B	14.4B
2014	18.5B	18.7B	19.0B	19.2B
2013	18.2B	18.2B	18.2B	18.3B
2012	17.1B	18.0B	18.0B	18.3B
2011	12.9B	13.4B	14.8B	16.1B
2010	11.2B	11.8B	12.2B	12.6B
2009	11.8B	11.0B	10.5B	10.8B
2008	0	11.4B	11.9B	12.3B
2007	0	0	0	11.0B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Danaher Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 01, 2024	weidemanis joakim	acquired	-	-	978	executive vice president
Mar 01, 2024	couchara georgeann	acquired	-	-	1,466	svp, human resources
Mar 01, 2024	bouda christopher	acquired	-	-	978	vp, chief accounting officer
Mar 01, 2024	gutierrez-ramos jose-carlos	acquired	-	-	2,932	svp, chief science officer
Feb 26, 2024	riley christopher paul	sold (taxes)	-136,820	253	-539	executive vice president
Feb 26, 2024	gutierrez-ramos jose-carlos	sold (taxes)	-219,825	253	-866	svp, chief science officer
Feb 26, 2024	raskas daniel	acquired	1,389,310	58.48	23,757	svp - corporate development
Feb 26, 2024	bouda christopher	sold (taxes)	-84,782	253	-334	vp, chief accounting officer
Feb 26, 2024	raskas daniel	gifted	-	-	-591	svp - corporate development
Feb 26, 2024	raskas daniel	sold	-5,986,760	252	-23,757	svp - corporate development

Which funds bought or sold DHR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Shepherd Financial Partners LLC	added	10.09	343,404	2,171,450	0.28%
Apr 23, 2024	Gradient Investments LLC	reduced	-26.96	-57,547	214,509	-%
Apr 23, 2024	BLODGETT WEALTH ADVISORS, LLC	unchanged	-	27,019	367,089	0.33%
Apr 23, 2024	CARDEROCK CAPITAL MANAGEMENT INC	reduced	-22.72	-1,013,010	5,095,290	1.43%
Apr 23, 2024	Accurate Wealth Management, LLC	added	3.82	24,266	358,694	0.10%
Apr 23, 2024	FISHMAN JAY A LTD/MI	reduced	-1.26	236,489	3,825,960	0.42%
Apr 23, 2024	DUPONT CAPITAL MANAGEMENT CORP	reduced	-10.17	-394,259	12,609,400	1.04%
Apr 23, 2024	McAdam, LLC	new	-	205,520	205,520	0.01%
Apr 23, 2024	EADS & HEALD WEALTH MANAGEMENT	reduced	-5.57	41,000	2,134,000	1.00%
Apr 23, 2024	Planning Center, Inc.	unchanged	-	29,077	395,057	0.09%

Are Funds Buying or Selling DHR?

Are funds buying DHR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DHR

No. of Funds

Unveiling Danaher Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	7.57%	55,935,935	SC 13G/A
Jan 26, 2024	blackrock inc.	6.9%	50,771,463	SC 13G/A
Feb 09, 2023	vanguard group inc	7.48%	54,428,553	SC 13G/A
Jan 31, 2023	blackrock inc.	7.1%	51,630,040	SC 13G/A
Mar 11, 2022	blackrock inc.	6.4%	45,990,561	SC 13G/A
Feb 09, 2022	vanguard group inc	6.99%	49,960,190	SC 13G/A
Feb 08, 2022	blackrock inc.	6.4%	45,990,561	SC 13G
Nov 02, 2021	rales mitchell p	4.99%	35,669,704	SC 13D/A
Jun 14, 2021	rales mitchell p	5.0%	35,669,704	SC 13D/A
Jun 14, 2021	rales steven m	6.1%	43,454,958	SC 13D/A

Recent SEC filings of Danaher Corp

View All Filings

Date Filed	Form Type	Document
Apr 23, 2024	10-Q	Quarterly Report
Apr 23, 2024	8-K	Current Report
Apr 23, 2024	IRANNOTICE	IRANNOTICE
Apr 12, 2024	PX14A6G	PX14A6G
Apr 01, 2024	25-NSE	25-NSE
Apr 01, 2024	S-3ASR	S-3ASR
Mar 27, 2024	ARS	ARS
Mar 27, 2024	DEF 14A	DEF 14A
Mar 27, 2024	DEFA14A	DEFA14A
Mar 05, 2024	4	Insider Trading

Peers (Alternatives to Danaher Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	174.4B	23.7B	-0.66%	-0.48%	39.62	7.35	-8.94%	-35.72%
IDXX	41.0B	3.7B	-6.96%	-1.95%	48.55	11.21	8.72%	24.44%
A	40.8B	6.7B	-5.62%	0.50%	33	6.06	-2.81%	-6.58%
DGX	15.1B	9.3B	5.76%	-6.69%	17.73	1.64	-6.38%	-9.73%
CRL	12.3B	4.1B	-11.91%	17.80%	25.98	2.99	3.86%	-2.39%
EXAS	11.5B	2.5B	2.30%	-4.05%	-56.49	4.61	19.93%	67.26%
MEDP	11.5B	2.0B	-0.40%	117.42%	36.88	5.87	25.57%	21.62%
NTRA	11.0B	1.1B	-1.39%	71.77%	-25.28	10.16	31.99%	20.63%
MID-CAP
NEOG	2.7B	929.2M	-19.07%	-29.09%	1.7K	2.87	28.93%	111.61%
GH	2.1B	563.9M	0.58%	-24.79%	-4.4	3.74	25.45%	26.76%
SMALL-CAP
CDNA	426.1M	280.3M	-13.73%	-2.49%	-2.24	1.52	-12.89%	-148.37%
ACRS	86.5M	31.2M	6.09%	-86.56%	-0.98	2.77	5.03%	-1.81%
AWH	41.8M	9.2M	-7.12%	-37.22%	-2.51	4.57	11.85%	44.12%
APDN	4.9M	9.0M	-42.00%	-72.12%	-0.68	0.55	-53.31%	2.21%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Danaher Corp News

Latest updates

Danaher Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-9.5%	5,796	6,405	5,624	5,912	5,949	7,134	6,455	6,528	6,526	3,497	7,229	7,218	6,858	6,760	5,884	5,297	4,343	4,868	4,378	4,445	4,220
Gross Profit	-7.7%	3,487	3,779	3,275	3,318	3,662	4,226	3,891	4,013	4,058	2,230	4,359	4,397	4,253	3,954	3,226	2,852	2,443	2,704	2,441	2,484	2,355
S&GA Expenses	114.4%	1,807	843	2,145	2,194	2,147	798	2,149	2,085	2,092	913	2,062	1,966	1,876	1,957	1,796	1,685	1,458	1,449	1,383	1,390	1,368
R&D Expenses	54.0%	368	239	417	418	429	236	420	431	441	251	441	426	380	396	342	323	287	294	283	282	268
EBITDA Margin	-8.2%	0.23*	0.25*	0.27*	0.28*	0.30*	0.30*	0.35*	0.31*	0.30*	0.30*	0.29*	0.29*	0.27*	0.24*	-	-	-	-	-	-	-
Interest Expenses	-16.7%	65.00	78.00	73.00	67.00	68.00	57.00	42.00	51.00	54.00	49.00	62.00	62.00	58.00	72.00	78.00	78.00	47.00	44.00	24.00	20.00	21.00
Income Taxes	331.6%	183	-79.00	268	286	348	-304	359	389	374	110	229	344	381	301	138	294	116	183	156	147	388
Earnings Before Taxes	178.1%	1,271	457	1,397	1,392	1,798	1,047	1,931	2,069	2,099	998	1,387	2,043	2,083	1,542	1,021	1,221	711	975	787	823	720
EBT Margin	-9.9%	0.19*	0.21*	0.23*	0.24*	0.26*	0.27*	0.31*	0.28*	0.27*	0.26*	0.25*	0.25*	0.24*	0.20*	-	-	-	-	-	-	-
Net Income	0.8%	1,088	1,079	1,129	1,106	1,429	2,210	1,551	1,658	1,684	1,788	1,158	1,785	1,702	1,241	883	927	595	1,256	668	731	334
Net Income Margin	-6.6%	0.19*	0.20*	0.24*	0.25*	0.26*	0.27*	0.29*	0.26*	0.26*	0.26*	0.21*	0.21*	0.19*	0.16*	-	-	-	-	-	-	-
Free Cashflow	19.0%	1,448	1,217	1,307	1,585	1,672	2,246	1,733	1,704	1,718	1,967	1,716	1,815	1,620	1,905	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.3%	83,402	84,488	87,734	84,902	85,040	84,350	81,030	81,806	83,392	83,184	82,498	78,027	75,426	76,161	72,891	71,268	68,930	62,082	61,531	53,322	51,774
Current Assets	3.1%	14,372	13,937	21,205	17,461	16,532	15,883	14,250	13,229	12,670	11,648	10,776	15,392	14,012	13,802	12,541	12,344	11,143	25,596	20,354	11,604	10,080
Cash Equivalents	19.9%	7,031	5,864	12,277	8,575	7,379	5,995	5,150	3,984	3,717	2,586	2,552	7,322	6,330	6,035	5,688	5,539	4,368	19,912	14,252	5,434	3,910
Inventory	2.0%	2,645	2,594	3,024	3,183	3,383	2,765	3,236	3,257	3,072	2,767	-	-	-	2,292	-	-	-	1,628	-	-	-
Net PPE	0.2%	4,562	4,553	4,302	4,176	4,065	3,709	3,719	3,794	3,815	3,530	3,640	3,410	3,266	3,262	3,052	2,973	2,989	2,302	2,520	2,542	2,504
Goodwill	-1.8%	40,846	41,608	39,155	39,576	39,856	37,276	35,850	39,276	40,663	38,682	41,237	35,590	34,880	35,420	34,270	33,227	33,726	22,713	25,725	26,075	26,001
Current Liabilities	-6.0%	7,778	8,274	9,367	8,404	8,730	8,389	8,002	7,556	7,547	8,140	7,257	6,825	6,824	7,402	6,038	5,600	8,466	4,932	5,934	5,008	4,633
Long Term Debt	-1.7%	16,417	16,707	19,513	18,285	18,261	19,086	18,542	20,052	21,768	22,168	23,591	20,400	20,267	21,193	21,806	22,370	22,737	21,517	16,536	10,144	9,458
LT Debt, Non Current	-100.0%	-	16,707	19,513	18,285	18,261	19,086	18,542	20,052	21,768	22,168	23,591	20,400	20,267	21,193	21,806	22,370	22,737	21,517	16,536	10,144	9,458
Shareholder's Equity	-0.1%	53,447	53,486	52,407	9.00	8.00	50,082	46,993	11,854	3,268	45,177	43,461	3,268	28,670	27,159	37,972	25,373	24,608	30,282	33,196	1,600	12.00
Retained Earnings	2.2%	41,962	41,074	42,272	41,344	40,437	39,205	37,177	35,808	34,332	32,827	31,231	30,264	28,670	27,159	26,088	25,374	24,609	24,166	26,481	25,955	25,369
Additional Paid-In Capital	0.5%	14,215	14,151	14,085	13,939	12,130	12,072	11,985	11,854	10,123	10,090	10,004	9,890	9,794	9,698	9,618	9,475	7,630	7,565	7,502	7,483	7,376
Accumulated Depreciation	3.4%	3,956	3,826	4,122	4,120	4,022	3,893	3,627	3,538	3,517	3,465	3,390	3,331	3,212	3,182	3,039	2,881	2,740	2,761	3,023	2,999	2,906
Shares Outstanding	0.2%	741	739	739	833	823	728	724	814	808	715	806	806	804	-	-	-	-	-	-	-	-
Minority Interest	25.0%	5.00	4.00	8.00	8.00	8.00	8.00	8.00	7.00	6.00	10.00	10.00	10.00	11.00	11.00	12.00	11.00	11.00	11.00	693	12.00	12.00
Float	-	-	-	-	158,100	-	-	-	167,300	-	-	-	173,700	-	-	-	113,200	-	-	-	91,100	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	7.4%	1,739	1,619	1,672	1,926	1,947	2,541	2,010	2,000	1,968	2,333	2,034	2,120	1,871	2,221	1,723	1,445	819	1,112	966	1,172	703
Share Based Compensation	130.8%	60.00	26.00	92.00	109	79.00	25.00	89.00	101	80.00	25.00	52.00	53.00	54.00	50.00	45.00	47.00	45.00	42.00	41.00	41.00	35.00
Cashflow From Investing	94.7%	-321	-6,017	-329	-431	-304	-816	-515	-400	-503	-879	-10,048	-1,067	-993	-581	-329	539	-20,868	-266	-244	-228	-498
Cashflow From Financing	94.1%	-133	-2,246	2,443	-208	-262	-906	-230	-1,160	-274	-1,422	3,305	-139	-449	-1,420	-1,319	-889	4,634	4,755	8,128	605	2,878
Dividend Payments	-100.0%	-	200	199	218	204	203	204	220	191	191	191	191	169	170	162	145	138	142	151	122	112

DHR Income Statement

2023-12-31

Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2021

Income Statement [Abstract]

Sales

$ 23,890

$ 26,643

$ 24,802

Cost of sales

(9,856)

(10,455)

(9,563)

Gross profit

14,034

16,188

15,239

Operating costs:

Selling, general and administrative expenses

(7,329)

(7,124)

(6,817)

Research and development expenses

(1,503)

(1,528)

(1,498)

Other operating expenses

(547)

Operating profit

5,202

7,536

6,377

Nonoperating income (expense):

Other income (expense), net

(175)

(227)

450

Loss on early extinguishment of borrowings

(96)

Interest expense

(286)

(204)

(231)

Interest income

303

Earnings from continuing operations before income taxes

5,044

7,146

6,511

Income taxes

(823)

(818)

(1,064)

Net earnings from continuing operations

4,221

6,328

5,447

Earnings from discontinued operations, net of income taxes

543

881

986

Net earnings

4,764

7,209

6,433

Mandatory convertible preferred stock dividends

(21)

(106)

(164)

Net earnings attributable to common stockholders

$ 4,743

$ 7,103

$ 6,269

Net earnings per common share:

Net earnings per common share from continuing operations, basic (in usd per share)

$ 5.70

$ 8.58

$ 7.39

Net earnings per common share from continuing operations, diluted (in usd per share)

5.65

8.47

7.28

Net earnings per common share from discontinued operations, basic (in usd per share)

0.74

1.22

1.38

Net earnings per common share from discontinued operations, diluted (in usd per share)

0.73

1.20

1.34

Net earnings per common share, basic (in usd per share)

6.44

9.80

8.77

Net earnings per common share, diluted (in usd per share)

$ 6.38

$ 9.66

^[1]

$ 8.61

^[1]

Average common stock and common equivalent shares outstanding:

Basic (in shares)

736.5

725.1

714.6

Diluted (in shares)

743.1

737.1

736.8

[1]	* Net earnings per common share amount does not add due to rounding.

DHR Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and equivalents	$ 5,864	$ 5,995
Trade accounts receivable, less allowance for doubtful accounts of $120 as of December 31, 2023 and $92 as of December 31, 2022	3,922	4,102
Inventories	2,594	2,765
Prepaid expenses and other current assets	1,557	1,741
Current assets, discontinued operations	0	1,280
Total current assets	13,937	15,883
Property, plant and equipment, net	4,553	3,709
Other long-term assets	3,644	4,160
Goodwill	41,608	37,276
Other intangible assets, net	20,746	19,821
Other assets, discontinued operations	0	3,501
Total assets	84,488	84,350
Current liabilities:
Notes payable and current portion of long-term debt	1,695	591
Trade accounts payable	1,766	1,856
Accrued expenses and other liabilities	4,813	4,815
Current liabilities, discontinued operations	0	1,127
Total current liabilities	8,274	8,389
Other long-term liabilities	6,017	6,498
Long-term debt	16,707	19,086
Long-term liabilities, discontinued operations	0	287
Stockholders’ equity:
Preferred stock, no par value, 15.0 million shares authorized; no shares issued and outstanding as of December 31, 2023; 1.72 million shares of 5.00% Mandatory Convertible Preferred Stock, Series B, issued and outstanding as of December 31, 2022	0	1,668
Common stock - $0.01 par value, 2.0 billion shares authorized; 880.5 million issued and 739.2 million outstanding as of December 31, 2023; 869.3 million issued and 728.3 million outstanding as of December 31, 2022	9	9
Additional paid-in capital	14,151	12,072
Retained earnings	41,074	39,205
Accumulated other comprehensive income (loss)	(1,748)	(2,872)
Total Danaher stockholders’ equity	53,486	50,082
Noncontrolling interests	4	8
Total stockholders’ equity	53,490	50,090
Total liabilities and stockholders’ equity	$ 84,488	$ 84,350

About Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

CEO	Mr. Rainer M. Blair
WEBSITE	danaher.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	65535

Danaher Corp Frequently Asked Questions

What is the ticker symbol for Danaher Corp? What does DHR stand for in stocks?

DHR is the stock ticker symbol of Danaher Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Danaher Corp (DHR)?

As of Tue Apr 23 2024, market cap of Danaher Corp is 174.42 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DHR stock?

You can check DHR's fair value in chart for subscribers.

What is the fair value of DHR stock?

You can check DHR's fair value in chart for subscribers. The fair value of Danaher Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Danaher Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DHR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Danaher Corp a good stock to buy?

The fair value guage provides a quick view whether DHR is over valued or under valued. Whether Danaher Corp is cheap or expensive depends on the assumptions which impact Danaher Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DHR.

What is Danaher Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, DHR's PE ratio (Price to Earnings) is 39.62 and Price to Sales (PS) ratio is 7.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DHR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Danaher Corp's stock?

In the past 10 years, Danaher Corp has provided 0.164 (multiply by 100 for percentage) rate of return.